rs1383147250
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000260.4(MYO7A):c.6551C>T(p.Thr2184Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,613,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.6551C>T | p.Thr2184Met | missense_variant | 48/49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.6431C>T | p.Thr2144Met | missense_variant | 48/49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.6404C>T | p.Thr2135Met | missense_variant | 49/50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.3977C>T | p.Thr1326Met | missense_variant | 28/29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.*1123C>T | non_coding_transcript_exon_variant | 31/32 | ENSP00000499323.1 | |||||
MYO7A | ENST00000670577.1 | n.*1123C>T | 3_prime_UTR_variant | 31/32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152272Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461678Hom.: 0 Cov.: 38 AF XY: 0.00000825 AC XY: 6AN XY: 727118
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152272Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74394
ClinVar
Submissions by phenotype
Usher syndrome Pathogenic:2
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 07, 2024 | Variant summary: MYO7A c.6551C>T (p.Thr2184Met) results in a non-conservative amino acid change located in the FERM domain (IPR000299) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 248994 control chromosomes (gnomAD). c.6551C>T has been reported in the literature in individuals affected with Usher syndrome or non-syndromic hearing loss who were compound heterozygous with other pathogenic/likely pathogenic variants (e.g. Yoshimura_2016, Carss_2017, Imizcoz_2023). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28041643, 26791358, 32581362, 32795431, 37811145). ClinVar contains an entry for this variant (Variation ID: 438179). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 18, 2023 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYO7A protein function. ClinVar contains an entry for this variant (Variation ID: 438179). This missense change has been observed in individual(s) with autosomal recessive deafness and/or autosomal recessive Usher syndrome (PMID: 26791358, 28041643). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 2184 of the MYO7A protein (p.Thr2184Met). - |
Usher syndrome type 1;C1832475:Autosomal dominant nonsyndromic hearing loss 11;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 08, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at